Stock ONCOBIOLOGICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Strategies Oncobiologics Inc Nasdaq

Equities

US68235M2044

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Oncobiologics Inc
28/05 Outlook Therapeutics Granted EU Marketing Authorization for Lytenava to Treat Wet AMD MT
28/05 Outlook Therapeutics, Inc. Receives European Commission Marketing Authorization for LYTENAVA? (bvacizumab grapa) for the Treatment of Wet AMD CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OTLK Stock
  4. Stock
  5. News Oncobiologics Inc
  6. MarketScreener Strategies